Adam Morgan - Jan 19, 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Adam Morgan
Stock symbol
HRTX
Transactions as of
Jan 19, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 09:04 PM
Previous filing
Oct 4, 2023
Next filing
Sep 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +13.9K +36.82% $0.00 51.8K Jan 19, 2024 Direct F1
holding HRTX Common Stock 6.99M Jan 19, 2024 By Velan Capital Master Fund LP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +83.7K $0.00 83.7K Jan 19, 2024 Common Stock 83.7K $2.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 19, 2025.
F2 Securities owned directly by Velan Master. Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.